Preparing for Cohort Review & Standard Forms for Cohort Presentation June 16, 2010 Kieran Hartsough.

Slides:



Advertisements
Similar presentations
SERVICE DELIVERY AS AN ENTRY POINT TO HEALTH SYSTEM STRENGTHENING A Case Study from Senegal: Improving the Tuberculosis System of Care Dr. Bruno Bouchet,
Advertisements

Your name Institution/organization Meeting Date. Introduction.
Contact Investigation for Tuberculosis Control
Evaluation of a new Health Code requirement for discharging infectious tuberculosis patients from NYC hospitals Michelle M. Macaraig, MPH Assistant Director.
VANDERBILT HOME CARE SERVICES Quality Of Documentation Of Rehab Staff Over The Course Of Patient Treatment.
National Tuberculosis Controllers Association
June 2004 HITCH Training Slide Set #3 Special Considerations in Antiretroviral Therapy.
Health Assessment Abnormal Cases. Objective Review Health Assessment Status transitions for abnormal cases Record HA (Health Assessment) Results for an.
TB Contact Investigation
World Health Organization TB Case Definitions
Nucleic Acid Amplification Test for Tuberculosis
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
International Standards of Tuberculosis Care Implementation by Pulmonologists in Private Practice in Jakarta E. Burhan 1, M. A. Nawas 1, D. Kusumo Sutoyo.
Utilizing Facility Data for Program Monitoring Valerie Koscelnik Track 1 ART Program Meeting Maputo, August 12, 2010.
Cross-cutting Capacity Building Needs of Proposed Local Partners Philippe Chiliade, MD,MHA HHS / HRSA Maputo, Mozambique August 12, 2010.
Diagnosis of TB.
Tuberculosis Follow up Care PA Department of Health Role Maxine Kopiec Community Health Nursing Supervisor April 24, 2015.
Module 10: Understanding Laboratory Data *Image courtesy of: World Lung Foundation.
Culture Conversion and Self- Administered Therapy in Privately Managed Tuberculosis Patients Melissa Ehman MPH, Jennifer Flood MD MPH, Pennan Barry MD.
Antiretroviral Treatment Costs in Mexico WHO/UNAIDS Workshop on Strategic Information for Anti-Retroviral Therapy Programmes 30 June to 2 July, 2003 Assessment.
Current international guidelines recommend 6–9 months of isoniazid (INH) preventive chemotherapy to prevent the development of active tuberculosis in.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
D etection of E arly Lung C ancer A mong M ilitary P ersonnel Study 1 Version
1385 / 5 / 15 نشست سالانه برنامه كنترل سل شهريور Tuberculosis & Air Travel.
1 Epidemiology of Pediatric Tuberculosis in the United States, 1993–2006 Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis.
Evaluating Tuberculosis Surveillance and Action in an Urban and Rural Setting Kristine Lykens, Ph.D. In collaboration with Anita Kurian, MPH, MBBS Patrick.
1 Module ON-SITE SUPERVISION OVERVIEW. 2 Content Overview What is on-site supervision? Advantages and disadvantages of on-site supervision Organization.
The Cohort Review Process The Cohort Review Process Kim Field RN, MSN WA State DOH Tuberculosis Program.
Tuberculosis Research of INA-RESPOND on Drug-resistant
1 Module OVERVIEW OF EXTERNAL QUALITY ASSESSMENT.
TB 101 Part II Brenda Mayes, R. N. March TREATMENT TB DISEASE MDR XDR LATENT TB INFECTION.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Elements of the Cohort Review Approach Harvey L. Marx, Jr. Lisa Schutzenhofer TB Program Controller TB Program Manager.
V IRGINIA C OHORT D ATA – 5 YEAR TRENDS AFTER 4 YEARS OF LOCAL COHORT REVIEW Virginia achievement on National TB Indicators for the past 5 years – where.
Comprehensive Field Record. Introduction to the Training ● The slides will first show a picture of the section of the template that will be discussed.
NAAT Is it Time for a New Option in California?. Background CDC 2009 guidelines recommend NAAT for each patient with suspected TB for whom the test result.
Comprehensive Field Record. Introduction to the Training ● The slides will first show a picture of the section of the template that will be discussed.
Data dissemination meeting February 28, 2007 ICAP New York.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
Integration of TB and HIV Screening, Care and Treatment in Mulago Hospital, Uganda Rhoda Wanyenze, Doris Mwesigire, Henry Luzze, Violet Gwokyalya, Julius.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
Commission on Teacher Credentialing Ensuring Educator Excellence 1 Common Standards August 19, :30 am-3:00 pm.
Labrador City Dec 2013 Identifying and Controlling the Hazards Above.
The Managerial Role In TB Interviewing and Large Scale Contact Investigations Eileen Napolitano for Mark Wolman NJ Medical School Global Tuberculosis Institute.
Rauni Ruohonen FILHA Priorities of TB control in penitentiary care.
Management of the Newborn When Maternal TB Suspected
Whole-Genome Sequencing; It’s Not Just For Epis
Guidance on completion of Isoniazid Preventive Therapy register
TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.
This is an archived document.
World Tuberculosis Day 2013
World Tuberculosis Day 2014
Fifth Pacific Stop TB meeting Fiji Islands, May 4-7, 2010
This is an archived document.
Nucleic Acid Amplification Test for Tuberculosis
World Tuberculosis Day 2015
World Tuberculosis Day 2014
Further explorations of surveillance data: case detection (all cases vs. bacteriologically confirmed, All strategies) Good afternoon. I will give a brief.
Tuberculosis in Wales Annual Report 2018 Data to the end of 2017
New Hampshire Training Cohort
Goal Objectives Expected Outcomes
TB epidemiology in Bulgaria
Using Whole Genome Sequencing Analysis in California
Surveillance, Monitoring and Evaluation Working Group
Interview Timeframes Conduct a minimum of 2 interviews: 1st interview
Stakeholder engagement and research utilization: Insights from Namibia
Tuberculosis in Wales Annual Report 2017 Data to the end of 2016
Uses of Genotyping.
M. Jacques Nsuami, MD, MPH Stephanie N. Taylor, MD
Presentation transcript:

Preparing for Cohort Review & Standard Forms for Cohort Presentation June 16, 2010 Kieran Hartsough

Page  2 Preparing for Cohort Review  Cohort preparation begins when cases are first reported  Preparation continues with regular case management  Case managers complete the demographic information on cohort forms  The remaining information is added as case information becomes known: During patient interview Through home assessment Chart review Clinic visits Contact elicitation and investigation Laboratory reports

Page  3 Standard Forms  Assist case management  Ensure concise case presentation  Collect essential patient and contact information  Assist in evaluation of key indicators New York City cohort presentation forms include: Pulmonary or Laryngeal TB Case Clinically Confirmed or Extrapulmonary TB Case

Page  4 NYC Presentation Form I : Pulmonary or Laryngeal TB To document cases that require a contact investigation: 2a) sputum smear+, pulmonary 2b) sputum smear -, sputum culture + 2c) pediatric; other resp smear and/or culture+; cavitary, culture -

Page  5 NYC Presentation Form II : Clinically confirmed or Extrapulmonary TB To document cases that do not require a contact investigation 2a) sputum smear+, pulmonary 2b) sputum smear -, sputum culture + 2c) pediatric; other resp smear and/or culture+; cavitary, culture -

Page  6 Information that captures essential information on TB cases and permits analysis of key indicators Key demographics Clinical characteristics Treatment regimen/duration/completion DOT/pharmacy checks Results of contact investigations Information on congregate site exposures Timeliness measures Laboratory results Standard Forms – what to include